Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Abstract

Abstract
The aim of this study was to develop and evaluate novel drug delivery systems for targeted cancer therapy, with the overarching goal of improving treatment outcomes and minimizing adverse effects associated with conventional chemotherapy. Cancer remains a significant global health challenge, with existing treatments often being limited by non-specific targeting and systemic toxicity. Drug delivery systems offer a promising approach to enhance the efficacy and safety of anticancer agents by improving their pharmacokinetic profile and targeting specific cancer cells or tissues. Chapter 1 provides an introduction to the research topic, including the background of the study, problem statement, objectives, limitations, scope, significance, structure of the thesis, and definitions of key terms. The literature review in Chapter 2 covers ten key areas related to drug delivery systems, cancer therapy, targeted drug delivery, nanomedicine, and various approaches to improve drug efficacy and reduce toxicity. Chapter 3 details the research methodology employed in this study, encompassing the design and synthesis of novel drug delivery systems, in vitro and in vivo evaluation of their anticancer efficacy, characterization of drug release profiles, and assessment of biocompatibility and safety profiles. The methodology also includes the use of advanced analytical techniques to study drug-target interactions and cellular uptake mechanisms. The findings discussed in Chapter 4 highlight the development of innovative drug delivery systems, such as nanoparticles, liposomes, micelles, and conjugates, designed to deliver cytotoxic agents specifically to cancer cells while sparing healthy tissues. The results demonstrate enhanced drug accumulation at the tumor site, improved therapeutic efficacy, and reduced systemic toxicity compared to conventional chemotherapy, paving the way for personalized and targeted cancer treatment strategies. In conclusion, Chapter 5 summarizes the key findings of the study and discusses their implications for the field of cancer therapy. The research underscores the potential of novel drug delivery systems to revolutionize the treatment of cancer by offering targeted and personalized approaches that maximize therapeutic benefits while minimizing side effects. Future directions include further optimization of drug delivery systems, clinical translation, and potential combination therapies to enhance treatment outcomes and patient quality of life. In summary, this thesis contributes to the advancement of drug delivery systems for targeted cancer therapy, with the ultimate goal of improving patient outcomes and advancing the field of cancer treatment.